Genome-wide allelotyping of a new in vitro model system reveals early events in breast cancer progression.
Toward the goal of identifying early genetic losses, which mediate the release of human breast epithelium from replicative suppression leading to cellular immortalization, we have used a newly developed in vitro model system. This system consists of epithelial cultures derived from noncancerous breast tissue, treated with the chemical carcinogen N-ethyl-N-nitrosourea, and continuously passaged to yield cell populations culminating in the immortal phenotype. Genome-wide allelotyping of early passage N-ethyl-N-nitrosourea-exposed cell populations revealed aberrations at >10% (18 of 169) loci examined. Allelic losses encompassing chromosomes 6q24-6q27, implicating immortalization-associated candidate genes, hZAC and SEN6, occurred in two independently derived cell lines before the Hayflick limit. Additional LOH sites were present in one cell line at 3p11-3p26, 11p15, and 20p12-13. Allelic losses reported in this cell line preceded detectable levels of telomerase activity and the occurrence of p53-related aberrations. Information gained from the search for early immortalization-associated genetic deletions in cultured cells was applied in a novel approach toward the analysis of morphologically normal terminal ductal lobular units microdissected from 20 cases of ductal carcinoma in situ. Notably, clonal allelic losses at chromosome 3p24 and 6q24 were an early occurrence in adjoining terminal ductal lobular units of a proportion of primary tumors, which displayed loss of heterozygosity (3 of 11 and 3 of 6, respectively). The biological insights provided by the new model system reported here strongly suggest that early allelic losses delineated in immortalized cultures and validated in vivo could serve as surrogate endpoints to assist in the identification and intervention of high-risk benign breast tissue, which sustains the potential for continuous proliferation.
Li
Zheng
Z
Geraldine Brush Cancer Research Institute, California Pacific Medical Center, San Francisco 94115, USA.
Meng
Zhen Hang
ZH
Sayeed
Aejaz
A
Shalaby
Refaat
R
Ljung
Britt-Marie
BM
Dairkee
Shanaz H
SH
D000483:Alleles; D001940:Breast / Q000166:cytology / Q000187:drug effects; D001943:Breast Neoplasms / Q000139:chemically induced / Q000235:genetics* / Q000473:pathology; D002448:Cell Adhesion / Q000502:physiology; D002455:Cell Division / Q000502:physiology; D002461:Cell Line, Transformed; D002471:Cell Transformation, Neoplastic / Q000235:genetics*; D018450:Disease Progression; D004847:Epithelial Cells / Q000166:cytology / Q000187:drug effects; D005038:Ethylnitrosourea; D017353:Gene Deletion; D019942:Genes, p16; D016158:Genes, p53; D006801:Humans; D019656:Loss of Heterozygosity; D019098:Telomerase / Q000378:metabolism; D016615:Telomere / Q000502:physiology
D019098:Telomerase; D005038:Ethylnitrosourea